Clinical trials and preclinical studies suggest that gut dysbiosis can impact PD progression by increasing intestinal permeability, aggravating neuroinflammation, aggregating abnormal α-synuclein fibrils, increasing oxidative stress, and decreasing neurotransmitter production [87]. The gene discussed is SNCA; the disease is Parkinson disease.